Combined synopsis and solicitation
NOI - A Non-Invasive Prognostic Biomarker - Circul
75N98027Q00007
National Institutes of Health, National Institutes of Health Olao. Testing Laboratories and Services.
Response deadline
October 23, 2026 at 9:00 AM EDT
Closed 9 days ago. Posted October 13, 2026. Scheduled to archive November 7, 2026.
Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities
This one closed 9 days ago
23 like it are open now in testing laboratories and services
- VACCHCS Pharmacy Certification
Department of Veterans Affairs, 261-Network Contract Office 21
Combined synopsis and solicitationNAICS 541380Fresno, CA36C26127Q0099Closes tomorrowNov 2 - Troubleshooting, Calibration and as-needed Remedial Repair of Proof Test Machines
Department of the Navy, Pearl Harbor Naval Shipyard Imf
SolicitationSmall businessNAICS 541380HawaiiN32253-27-Q-0001Closes tomorrowNov 2 - Full Scale Vehicle Crashworthiness Testing and Side Air Bag Out-of-Position Testing for the New Car Assessment Program (NCAP)
National Highway Traffic Safety Administration, 693JJ9 NHTSA Office of Acquistion
Sources soughtNAICS 541380Washington, DC693JJ927RQ000049Closes in 2 daysNov 3
Description
As published on SAM.gov.
(ii)The solicitation number is 75N98027Q00007. This solicitation is issued as a Notice ofIntent (NOI) for a non-competitive combined synopsis/solicitation to award a contract orpurchase order without providing for full and open competition (including brand-name, ifapplicable).
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to University of Alabama at Birmingham, 701 S 20th Street, Birmingham, AL 35294-0001-0001, for research support to develop and validate circulating cell-free DNA (cfDNA) as a blood-based biomarker of chlorine-induced acute lung injury, using the Matalon Laboratory's sole-source validated murine chlorine inhalation injury model, established mechanistic expertise, access to its actively enrolling aspiration pneumonitis biorepository (human proxy cohort), existing collaborative infrastructure with the NHLBI Laboratory of Precision Omics, and continuity with peer-reviewed federal funding (NIH R01 HL031197). These capabilities are not available from any other source and are essential to the project's feasibility.
(iii)The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026.
(iv)The associated NAICS code is 541380, Testing Laboratories and Services, and the small business size standard is $19.0 million. This requirement is not set aside for small business.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- Sol_75N98027Q00007.pdf278 KB, October 13, 2026
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
October 13, 2026
Combined synopsis and solicitation
Due October 23, 2026 at 9:00 AM EDT. SAM.gov, notice 66af16818b144456af1ddc0d52fc9378
1 revisions on SAM
- October 13, 2026: publish, combined synopsis and solicitation
Points of contact
- CAPOBIANCO, NICHOLAS Snicholas.capobianco@nih.gov+1 000 000 0000